Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Douyin is a leading short-video social media platform in China, owned and operated by ByteDance. While primarily a technology and entertainment entity, it has become a significant channel for healthcare information, medical education, and telemedicine marketing. The platform facilitates interactions between healthcare professionals and the public, hosting a vast array of health-related content. Its parent company, ByteDance, has further expanded into the healthcare sector through the acquisition of hospital groups and the development of the Xiaohe Health platform. Douyin itself does not engage in traditional biotechnology research, drug discovery, or clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Douyin.